Sorrow and Progress
I was looking forward to writing and sharing good news from the past week. I’ll still do that here in my blog, because as a group united against cancer, we must continue to keep our eye on the ball and celebrate our victories.
However, my message this week must begin on a sad note.
|
|
Ralph Lauren Corporate Foundation Makes Gift to Address Disparities in Cancer Care
The Ralph Lauren Corporate Foundation, continuing its longstanding partnership with Georgetown Lombardi, has made a gift to establish the Ralph Lauren Center for Cancer Prevention. This gift — part of the foundation’s $25 million commitment to support five cancer care and prevention programs — will address health disparities in cancer detection, diagnosis, treatment, and prevention for underserved communities across the Washington, DC, region. Read more about this news.
|
|
Study Shows Sleep Disturbances During the Pandemic Were Similar Between Breast Cancer Survivors and Healthy Controls
Results from the Thinking and Living with Cancer Study showed that the development of sleep disturbances during the early months of the COVID-19 pandemic increased symptoms of depression and anxiety among older women, but the findings did not differ between women who survived breast cancer and women without cancer. The study, the first to assess sleep disturbances and mental health outcomes among cancer survivors during the pandemic, was published in the journal Cancer Medicine by researchers from Georgetown Lombardi and Hackensack Meridian John Theurer Cancer Center, along with other investigators. Read more about this research.
|
|
Join BellRinger on Bike to Work Day |
|
Celebrate Bike to Work Day with BellRinger on Friday, May 20 at the Georgetown Waterfront Park pit stop from 7:00 – 9:00 a.m.! We will be located right off the Capital Crescent Trail near the intersection of K Street & Wisconsin Avenue NW. Stop by and ask about how you can join us to ride in BellRinger this October, a bike ride and community movement supporting cancer research at Georgetown Lombardi. Contact Jonathan Thomas to learn more, or visit us online at BellRinger.org. |
|
Research Seed Funding Available from the Earth Commons
|
|
Tuesday, May 17
12:00 - 1:00 p.m.
Andrew David Patterson, PhD, Smith Professor and professor of molecular toxicology, Pennsylvania State University, presents “Understanding Bile Acid Biology Through Metabolomics.” Join the seminar via Zoom.
|
|
Virtual Staff/AAP Community Forum
Wednesday, May 18
10:00 a.m.
|
|
18th Annual MAGIS Society of Master Teachers Induction Ceremony
Thursday, May 19
5:00 p.m.
LA-6, Pre-Clinical Science Building
Join the MAGIS Society of Teachers as we honor physicians and biomedical scientists dedicated to the care of others and the health needs of our society.
|
|
Evidence-Based Approaches for Scientific Manuscript Writing: Strategies for Non-Native English Speakers
Wednesday, May 25
9:00 - 10:30 a.m.
Lourdes Albo-Beyda, MA, adjunct professor at Broward College, shares evidence-based strategies for scientific manuscript writing for non-native English speakers. Open to all faculty, staff and students. Held in the Research Auditorium and via Zoom. RSVP for this workshop.
|
|
Know Your Worth Series: Academic Frontlines Panel
Thursday, May 26
12:00 - 1:00 p.m.
Join leadership from the Office of Diversity, Equity & Inclusion and Georgetown Women in Medicine, with co-presenters from GUMC Human Resources, for the third in this series of “how-to” presentations, in which a seasoned panel of Georgetown leaders addresses navigating career and leadership pathways. Open to all faculty and staff. Attendees receive an information packet with tools and strategies. RSVP for this online workshop.
|
|
Funding and Award Opportunities |
|
2022 Cancer Center Support Grant Developmental Funds Awards
Cancer Center Support Grant (CCSG) Developmental Funds Awards (one-year award at $10,000-$50,000), funded through Georgetown Lombardi’s CCSG, which is funded by NCI. Developmental funds, are available to all Georgetown Lombardi members with a cancer relevant research focus, including basic, clinical, translational or population sciences, with the exception that investigators who have received developmental funds twice within the last five years will not be eligible for additional funds. Projects must begin no later than Sept. 1, 2022, and be completed by Aug. 31, 2023. View full announcement. All applications are due Monday, June 6, to Sharon Levy (SGL5@georgetown.edu).
|
|
IDEAL (Inclusion, Diversity, Equity, Anti-racism at Lombardi) Grants Request for Proposals
IDEAL Grants aim to contribute to a culture of respect, inclusion and belonging. These grants (12-month awards up to $10,000) are available to all Georgetown Lombardi members (any track, any rank). We anticipate funding four to five awards. Proposals must describe activities that promote diversity, equity, inclusion and/or anti-racism in any aspect relevant to the mission of Georgetown Lombardi, including research, teaching, service, clinical care and community outreach and education. Proposals aligned with the National Cancer Institute’s Goals for Inclusion and Equity are welcome. View full IDEAL Grant announcement. Proposals are due by 11:59 p.m. on Monday, June 6. Submit proposals by email to Kristi.Graves@georgetown.edu. Award notifications will be made end of June / early July 2022, and funding will be awarded for use July 1, 2022, to June 30, 2023.
|
|
Request for Applications: ACS Research Priority Area: Screening
The American Cancer Society has announced a new RFA focused on testing innovative solutions to improve cancer screening and early detection. This could entail better implementing existing screening tests, adapting current tests and technologies, or developing new tools. Funds will support at least two Interdisciplinary Team Awards, seven Research Scholar Grants, and two Clinician-Scientist Development Grants. View full details on eligibility, scientific scope, application deadlines and more. Letter of Intent due June 15, submitted via proposalCENTRAL.
An informational webinar and Q&A will be held on May 16 from 12:00 – 1:00 p.m. Register here.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:00 PM | No Conference — Fellows Monthly Research Lecture Postponed
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | Dr. Tesfaye — Gastric Cancer | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom
9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Podium A / Microsoft Teams
12:15 PM | Dr. Blair DeStefano — Cancer Risk Factors | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Chaz Hinzman | Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Aaron with Pattern – Disability Insurance for Trainees | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: None
12:15 PM | No Lecture | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
